Cargando…
Systematic review of immunomodulatory therapies for hidradenitis suppurativa
Background: Greater understanding of the roles of tumor necrosis factor-α, IL-1β, IL-10, and the IL-23/T-helper (Th) 17 and IL-12/Th1 pathways in immune dysregulation in moderate/severe hidradenitis suppurativa (HS) has helped in developing new regimens. We aim to review the use of different immunom...
Autores principales: | Lim, Shi Yu Derek, Oon, Hazel H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526329/ https://www.ncbi.nlm.nih.gov/pubmed/31190730 http://dx.doi.org/10.2147/BTT.S199862 |
Ejemplares similares
-
Management of severe hidradenitis suppurativa with biologic therapy and wide excision
por: Lim, Shi Yu Derek, et al.
Publicado: (2019) -
Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities
por: Lim, Ziying Vanessa, et al.
Publicado: (2016) -
The effect of oral clindamycin and rifampicin combination therapy in patients with hidradenitis suppurativa in Singapore
por: Ochi, Harumi, et al.
Publicado: (2018) -
Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa—Possibilities and Limitations
por: Świerczewska, Zuzanna, et al.
Publicado: (2022) -
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2023)